Analysis of Venture Capital Investment Trends in the North American and European Healthcare Industry

Description

Analysis of Venture Capital Investment Trends in the North American and European Healthcare Industry PR Newswire MOUNTAIN VIEW, California, Dec. 13, 2012 - Frost & Sullivan hosts complimentary webinar discussing early- to late-stage funding and high to low deal value MOUNTAIN VIEW, California, Dec. 13, 2012 /PRNewswire/ -- WHEN: 11:00 a.m. ET on Thursday, Dec.

Informations

• Publié par: frost-sullivan
• Nombre de lectures: 11
• Langue: English

Extrait

Analysis of Venture Capital Investment Trends in the North American and European Healthcare Industry

PR Newswire MOUNTAIN VIEW, California, Dec. 13, 2012

- Frost & Sullivan hosts complimentary webinar discussing early- to late-stage funding and high to low deal value

MOUNTAIN VIEW, California,Dec. 13, 2012/PRNewswire/ --

WHEN: LOCATION:

SPEAKER:

11:00 a.m. ET on Thursday, Dec. 20, 2012

Online, with complimentary registration

Frost & SullivanBusiness and Financial Services

Research Analyst Dr. E. Saneesh

In the current state of the global economy, in which fundraising has become tight and there are decreasing opportunities to exit, venture capital (VC) firms are extremely cautious in choosing their investments. This briefing will investigate the historical trends of VC investments and key areas of investment in the European and North American healthcare industry.

Why you should attend:

Learn about key trends in the VC industry Discover the segments attracting VC investments in the European and North American healthcare industries Participate in a live Q&A session with the analyst

This briefing will benefit VC, financial, private equity, and strategic investors, as well as startup companies. This presentation will inform participants about key trends so investors are better positioned to make informed judgments before investing in specific segments or companies.

Supporting Quote "The pharmaceutical and biotechnology segments have become more mature, with a shift from VC investments to more strategic investments," said Frost & Sullivan Research Analyst Dr. E. Saneesh. "This is shown by the decrease in the number of VC deals in these segments; however, the healthcare equipment segment has displayed increases in the number of investments. The consolidating VC industry has also contributed to the reduction in the number of VC deals globally."

Supporting Resources For more information about Frost & Sullivan'sBusiness and Financial Servicespractice, please visit: http://bit.ly/UElhNw.

Registration

To attend the briefing, [e-mail] full name, job title, company name, company telephone number, company email address and web site, city, state and country. Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.

About Frost & Sullivan Frost & Sullivan, the Growth Partnership Company, w orks in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Propositionprovides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation. The Partnership Infrastructureis entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of m ore than 40 offices.